Hayley Wilson

@thehjbrod.bsky.social

Policy analyst (biomedical science) at PHG Foundation. Research interests include pathogen genomics, AMR, genomic medicine and closing research to implementation gaps.

Exciting News in Gene Therapy!  NICE has approved the use of gene therapy exa-cel for treating sickle cell disease! This groundbreaking development offers new hope for patients and marks a significant milestone in medical science. 🧬✨ www.phgfoundation.org/news/worlds-...

World’s first gene editing therapy now in the UK for sickle cell disease - PHG Foundation

The approval by NICE of Exa-cel provides new hope for people living with sickle cell disease.

phgfoundation.org